Publicacións en colaboración con investigadores/as de Hospital POVISA (35)

2023

  1. The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study

    Neurological Sciences, Vol. 43, Núm. 4, pp. 2537-2544

  3. Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

    Brain Sciences, Vol. 12, Núm. 11

2021

  1. A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

    Cancer, Vol. 127, Núm. 12, pp. 2003-2014

  2. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

  3. Differences in the clinical profile and management of atrial fibrillation according to gender. Results of the registro gallego intercéntrico de fibrilación auricular (regueifa) trial

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  4. Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method

    Healthcare (Switzerland), Vol. 9, Núm. 6

  5. Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

    Advances in Therapy, Vol. 38, Núm. 10, pp. 5398-5411

  6. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

  7. Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice

    Respiratory Medicine, Vol. 187

  8. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  9. Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter

    Neurologia, Vol. 36, Núm. 5, pp. 346-352

  10. Rationale, design and basal characteristics of REGUEIFA study (Multicenter Registry of Atrial Fibrillation in Galicia)

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 197-207

2020

  1. Covid 19 and venous thromboembolic disease. Review on a series of patients

    Galicia Clínica, Vol. 81, Núm. 3, pp. 66-69

  2. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  3. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial

    Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502

  4. Intensive care in Spain

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 3, pp. 147-152

2019

  1. Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain

    Infection, Vol. 47, Núm. 3, pp. 399-407

  2. Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen

    Annals of Oncology, Vol. 30, pp. iv42-iv43